BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 5357395)

  • 1. [Apparently primary kidney disease revealing latent error of purine metabolism in 2 adolescents].
    Lagrue G; Canlorbe P; Busuttil R
    Ann Pediatr (Paris); 1969 Oct; 16(10):567-72. PubMed ID: 5357395
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperuricemia and gout. Classification, complications and management.
    Boss GR; Seegmiller JE
    N Engl J Med; 1979 Jun; 300(26):1459-68. PubMed ID: 221806
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathogenesis and therapy of gout].
    Mertz DP
    Med Klin; 1971 Apr; 66(17):623-6. PubMed ID: 4994876
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic aberrations in gout.
    Seegmiller JE
    Clin Orthop Relat Res; 1970; 71():87-98. PubMed ID: 5270558
    [No Abstract]   [Full Text] [Related]  

  • 5. [Typing of hypouricemia (uric acid clearance)].
    Tsutani H; Takagi K
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():357-60. PubMed ID: 12629746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Familial encephalopathy with hyperuricemia. A study of purine metabolism and therapeutic attempts].
    Labrune B; Cartier P; Bonnenfant F; Ribierre M; Mallet R
    Arch Fr Pediatr; 1969 Feb; 26(2):139-54. PubMed ID: 5375873
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperuricemia and gout in monolism].
    Carcassi A
    Reumatismo; 1977; 28(2):63-70. PubMed ID: 141077
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urine fibrinolytic activity as an indicator of kidney damage in uric acid metabolic imbalance].
    Shcherbak AV; Balkarov IM; Kozlovskaia LV; Podorol'skaia LV; Gindis AA
    Ter Arkh; 2001; 73(6):34-7. PubMed ID: 11521518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is certain in gout therapy?].
    Gottesbüren H; Strohmeyer G
    Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of endogenous uric acid synthesis with allopurinol in gout and urate diathesis. Remarks on E. Holländer and P. Schwarczmann, Münch. Med. Wschr. 3 (1969) 32, 1623-1626].
    Zöllner N
    Munch Med Wochenschr; 1970 Dec; 112(49):2263-4. PubMed ID: 5536821
    [No Abstract]   [Full Text] [Related]  

  • 11. [Allopurinol: its clinical use].
    Zucchelli P; Sasdelli M; Fusaroli M
    G Clin Med; 1968 Oct; 49(10):1014-37. PubMed ID: 5735670
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of allopurinol therapy on kidney processes concomitant with gout].
    Poór G; Jósfay J; Judák A; Ludányi E; Mituszova M
    Orv Hetil; 1987 Sep; 128(37):1939-43. PubMed ID: 3313182
    [No Abstract]   [Full Text] [Related]  

  • 13. Gout and pseudogout: crystal-induced arthropathies.
    Pritchard MH
    Clin Endocrinol Metab; 1981 Mar; 10(1):141-61. PubMed ID: 7014045
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of organic brain syndrome with seizures and hyperuricosuria subsequent to allopurinol therapy.
    Coleman M
    Trans Am Neurol Assoc; 1971; 96():113-7. PubMed ID: 5159063
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of serum acid levels in children in comparison with adults and the incidence of purine metabolism disorders and concomitant diseases in children of families with gout].
    Schröder HE; Mank H; Mende T; Heinrich JJ
    Z Gesamte Inn Med; 1985 Apr; 40(8):221-6. PubMed ID: 4013437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with allopurinol in gout and hyperuricemic renal disease].
    Hood B; Olander R
    Lakartidningen; 1973 Mar; 70(13):1297-300. PubMed ID: 4699017
    [No Abstract]   [Full Text] [Related]  

  • 18. [Osteo-onychodysplasia with nephropathy. Anatomo-clinical study].
    Manigand G; Auzepy P; Paillas J; Cohen de Lara AC; Deparis M
    Sem Hop; 1971 Dec; 47(52):2949-56. PubMed ID: 4334458
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding hyperuricemia: nursing implications.
    Johnson ES
    Nurs Clin North Am; 1972 Jun; 7(2):399-406. PubMed ID: 4482424
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.